$54.19
+2.41 (+4.65%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
-19.5% upside
Low Target
$27.22
Average Target
$43.60
High Target
$49.94
Current Price
$54.19
Current
$54.19
$54.19
Target
$43.60
$43.60
$27.22
$43.60 avg
$49.94
Scenario Analysis
Bear Case
$27.22
-49.8%
Low target
Base Case
$43.60
-19.5%
Avg target
Bull Case
$49.94
+-7.8%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$55.60
-2.5% from high
52-Week Low
$28.95
+87.2% from low
Target vs 52W High
$43.60
-21.6% vs high
Next Earnings Report
Nov 11, 2026
3d
until earnings
EPS Est: $0.06
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |